The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population.
Saved in:
| Title: | The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population. |
|---|---|
| Authors: | Beyerlin K; Massachusetts General Hospital, Boston, MA, USA., Jimenez R; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Zangardi M; Massachusetts General Hospital, Boston, MA, USA., Fell GG; Dana-Farber Cancer Institute, Boston, MA, USA., Edmonds C; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Johnson A; Massachusetts General Hospital, Boston, MA, USA., Bossuyt V; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Specht M; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mulvey TM; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Moy B; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ellisen LW; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Isakoff SJ; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Bardia A; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Spring LM; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA. |
| Source: | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Dec; Vol. 27 (8), pp. 1883-1890. Date of Electronic Publication: 2020 Nov 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
